Condition: Cervical Cancer · Sponsor: M.D. Anderson Cancer Center
The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.
This description comes directly from the study's public registry record.
Mila Salcedo, MD, PhD · (832) 696-6794 · mpsalcedo@mdanderson.org
Always discuss trial participation with your own doctor first.
| M D Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| José Macamo General Hospital and Health Center | Maputo, Mozambique | Recruiting |
| Maputo Central Hospital | Maputo, Mozambique | Recruiting |
| Mavalane Hospital and Health Center | Maputo, Mozambique | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05372484